For the Quarter Ending December 2022
North America
The North American market for Atenolol API witnessed turbulence during the fourth quarter of 2022. Due to high manufacturing costs, numerous logistical challenges, and increasing inflation, prices started to rise in Q4 2022 and continued to do so throughout the second month of the fourth quarter, with values accessed at USD 47650/MT CFR New York.
Rising transportation costs and port congestion at the main ports also helped to keep the market situation positive. In addition, the market situation improved due to the decrease in API output driven by higher energy prices. Later in December, prices started to drop due to easing inflation and a drop in end-user sector demand as the holiday season drew near. In December, the Atenolol API settlement price fell to USD 46355/MT CFR in New York.
Asia
The fourth quarter of 2022 was extremely volatile for the Asia Pacific Atenolol API industry. It was observed that rising end-user sector demand, several logistical difficulties, and rising inflation would cause prices to increase through the second month of the quarter. The prices accessed at the termination of the second month of Q4 were USD 40870/MT FOB Shanghai. Due to growing production costs driven by rising energy prices as well as increased domestic production to meet demand from both domestic and international markets, the market remained competitive. The strict zero covid regulations and frequent lockdowns in the Chinese regions have influenced the market. As domestic retailers had enough inventory by the end of December, the prices suddenly declined with the settlement price of USD 39655/MT FOB Shanghai.
Europe
Prices for Atenolol API fluctuated across the European region during the fourth quarter of 2022. It was observed that there was a consistent demand for Atenolol API in the pharmaceutical industry's downstream market. In the first two months of Q4 022, supply disruption and persistent port congestion in the European region led to price increases. Due to the impending Christmas season and the need to get ready for upcoming orders, retailers in Europe have decided to refill their inventories significantly. However, prices fell sharply in December due to a decline in inflation, relief from port congestion, and a minor increase in merchants' current stocks. The cost of Atenolol API was USD 48555/MT CFR Hamburg toward the end of Q4 2022
For the Quarter Ending September 2022
North America
During the third quarter of 2022, the Atenolol API market showcased an upward price trajectory with successive inclination in the prices of Atenolol API in the North American region owing to increased demand fundamentals and supply crunch. At the onset of the first half of Q3 2022, surging demand from the downstream pharma industry prompted the Atenolol API market prices to showcase a hiked-up trajectory in the domestic market. The increased prices of Key Starting materials (KSM), the surge in solvent prices, and the rise in freight and energy cost continued to pressure the US Atenolol market. In the last month of Q3, the prices decreased significantly. At the termination of Q3 2022, the value accessed was USD 43070/MT with an average quarterly inclination of 2.70%
Asia
During the third quarter of 2022, Asia's Atenolol API market has been showcasing a stable price trajectory. With the commence the first month of Q3 till the end of the second-month price increased significantly. Demand from the downstream end-user pharmaceutical industries increased compared to the previous quarter. A spurt in the values of raw materials imported from China, along with a significant surge in freight charges, packaging material, and transportation costs, in the wake of the Covid-19 pandemic, has derailed the Indian pharmaceutical industry's cost-effectiveness and expansion plans. In the last month, the price drop owns considerably with ease in demand and lowering input and production costs. Towards the termination of Q3 2022, the values were accessed at USD 37520/MT with a quarterly declination of 0.09%.
Europe
In the European region, Atenolol API market dynamics showcased ascending price trajectory with surging demand from the downstream pharmaceutical industry. Over and above, increasing manufacturing costs and lowering production rates kept the market tight. The regional markets experienced flexible market sentiments. The prices kept surging in the first two months with growing demand and increased freight charges. However, in the last month of Q3 2022, the market suddenly dropdown affecting the Atenolo price as traders were propelled to reduce their quotations with existing inventories. Further low operating rates followed by steady demand from the downstream pharmaceutical industry kept the market at ease. Towards the termination of Q3 2022, the atenolol prices were recorded at USD 46010/MT with a quarterly inclination of 1.61%.
For the Quarter Ending June 2022
North America
During the second quarter of 2022, the Atenolol API market showcased a upawrsd price trajectory with successive inclination in the prices of Atenolol API in the North American region owing to increased demand fundamentals and supply crunch. At the onset of the first half of Q2 2022, enough inventories and low demand support prompted the atenolol API market prices to remain firm in the domestic market. At the beginning of the 2nd month, the prices increased significantly. The increased prices of Key starting materials (KSM), the surge in solvent prices, and the rise in freight and energy cost continued to pressure the US market. At the termination of Q2 2022, the value accessed was USD 39990/MT with a quarterly inclination of 9.89%
Asia
During the second quarter of 2022, Asia's Atenolol API market has been showcasing an upward price trajectory. Demand from the downstream end-user pharmaceutical industries increased compared to the previous quarter. A spurt in the values of raw materials imported from China, along with a significant surge in freight charges, packaging material, and transportation costs, in the wake of the Covid-19 pandemic, has derailed the Indian pharmaceutical industry's cost-effectiveness and expansion plans. Towards the termination of Q2 2022, the values were accessed at USD 37740/MT with a quarterly inclination of 7.78%.
Europe
In the European region, atenolol market dynamics showcased a stable price trajectory with firm demand from the downstream pharmaceutical industry. Over and above regular manufacturing costs and lowering production rates kept the market stable. The regional markets experienced flexible market sentiments. The traders were propelled to reduce their quotations with surplus supply and existing inventories. Further low operating rates followed by steady demand from the downstream pharmaceutical industry kept the market at ease. Towards the termination of Q2 2022, the atenolol prices were recorded at USD 44120/MT with a quarterly inclination of 0.80%.
